Yadira Montijo-Torrado

• Educated and demonstrated products features and benefits to influence customers decisions to choose AZ portfolio, as the best options for each patients needs.
• Answered questions and persuasively overcame objections.
• Developed and maintained comprehensive understanding of products, services and competitors to enhance sales presentations.
• Collaborated with cross-functional teams to identify and address customer needs.
• Used customer insights to develop innovative sales strategies to increase sales.
• Provided support in key business accounts such as: Multidisciplinary Diabetes clinic, 330 Federal Accounts, Villa Los Santos Clinic Center, Internal Medicine Dept. Dr. Susoni Hosp., Pavia-Arecibo Hosp. and Doctor's Center Hosp. among others.
• Developed and implemented marketing plans to increase brand awareness and drive sales.
• 2023 Matrix Data Q-1 - QTD week 3/31

North territory - Farxiga: 59.28% NRx MS (achieved market leadership). Breztri: 18.70% NRx MS

2023 Matrix Data Q-2 - QTD week 5/19

Farxiga: 62.89 NRx MS (achieved market leadership). Breztri: 21.74% NRx MS.

2022 FSIP 1st Qtr Farxiga franchise: 122.22 %

Breztri : 140.45%

2nd Qtr Farxiga franchise: 104.76%

Breztri : 137.88%

2021 - 1st semester Farxiga brand weighted performance: 102.92%.

2nd semester October - Farxiga brand weighted performance 97.12%.

YTD - October Brand performance 101.20%

2020 - NRx M/S 4 QTr : Farxiga franchise 93.28%

Breztri: 120.20%

Yr End portfolio weight average 102.54%

• 2022 December CEO Ranking 5th.
• 2021 December CEO Ranking 7th.